Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DMIIR/Operating margin

DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) Operating margin

DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) operating margin by fiscal year — reported operating income divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to DMIIR

Source: SEC XBRL filings · For reference only · Not investment advice

More DMIIR financial trends

DMIIR RevenueDMIIR Net incomeDMIIR Net marginDMIIR Gross profitDMIIR Gross marginDMIIR Operating incomeDMIIR Operating cash flowDMIIR Free cash flowDMIIR Capital expendituresDMIIR Return on equityDMIIR Stock buybacksDMIIR Dividends paidDMIIR Total assetsDMIIR Total liabilitiesDMIIR Shareholders’ equityDMIIR overview →